Document Preview Unavailable

Safety, tolerability, pharmacokinetics, and pharmacodynamics of HBM9161, a novel FcRn inhibitor, in a phase I study for healthy Chinese volunteers

Yap, Desmond Y H; Hai, Jojo; Lee, Paul C H; Zhou, Xueying; Lee, Michael; et al.  Clinical and Translational Science Vol. 14, Iss. 5,  (Sep 2021): 1769-1779.

You might have access to this document